Related Experiment Video
Updated: Apr 15, 2026

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
Non-inferiority margins employed in clinical trials in Japan
1Department of Clinical Trial and Clinical Epidemiology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
What Is Known And Objective:
Determination of the non-inferiority margin is one of the major and most difficult considerations when planning a non-inferiority clinical trial. This article aims to list the non-inferiority margins employed in recent clinical drug-development trials in Japan.
Methods:
We investigated non-inferiority margins by reviewing new drug-development dossiers for drugs approved between January 2010 and December 2012 in Japan.
Results And Discussion:
We identified 174 non-inferiority trials, where the efficacy of the test drug was compared to that of a control drug. We have described 70 clinical endpoints and the corresponding non-inferiority margins. In antidiabetes drug trials, a margin of 0·4% mean difference in haemoglobin A1c level was used most frequently. In trials for glaucoma and ocular hypertension, 1·5 mmHg mean difference in intra-ocular pressure value was the commonest margin. A 10% margin of proportion difference was the most frequently chosen in trials of anti-infection drugs. We have provided a short description of the methods used to determine the non-inferiority margin.
What Is New And Conclusion:
We report on the non-inferiority margins used for a range of endpoints in recent drug-development trials for a number of different diseases. We hope that the details would be helpful to those appraising, reporting or designing non-inferiority trials.
More Related Videos
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
05:16Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
Published on: May 7, 2020
Related Concept Videos
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Bioequivalence studies: Biowaivers
Bioequivalence Data: Statistical Interpretation
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioequivalence: Overview